These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20410917)

  • 1. Swedish hypertension open care retrospective study in men and women (SHOW).
    Ljungman C; Collén AC; Manhem K
    J Hum Hypertens; 2011 Jan; 25(1):32-7. PubMed ID: 20410917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective.
    Thoenes M; Neuberger HR; Volpe M; Khan BV; Kirch W; Böhm M
    J Hum Hypertens; 2010 May; 24(5):336-44. PubMed ID: 19798089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modeling of systolic blood pressure reaction to antihypertensive agents in people with hypertension].
    Wu Y; Li YS; Bejan-Angoulvant T; Gueyffier F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):309-14. PubMed ID: 21624305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Hypertension Optimal Treatment (HOT) study: results of 12-month therapy related to age].
    Kolloch RE; Rahn KH
    Dtsch Med Wochenschr; 1998 Jan; 123(1-2):1-5. PubMed ID: 9465848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism.
    Kudoh T; Nagawaga T; Nakagawa I
    Hypertens Res; 2008 Mar; 31(3):455-62. PubMed ID: 18497464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
    Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive treatment and control in a large primary care population of 21 167 patients.
    Qvarnström M; Wettermark B; Ljungman C; Zarrinkoub R; Hasselström J; Manhem K; Sundström A; Kahan T
    J Hum Hypertens; 2011 Aug; 25(8):484-91. PubMed ID: 20720572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden.
    Journath G; Hellénius ML; Petersson U; Theobald H; Nilsson PM;
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):258-62. PubMed ID: 18525379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential pulse pressure response to various antihypertensive drug families.
    Karpanou EA; Vyssoulis GP; Stefanadis CI; Cokkinos DV
    J Hum Hypertens; 2006 Oct; 20(10):765-71. PubMed ID: 16855624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.